Marketing multi-potent cord blood cells

 The biotechnology company BioE, based in St. Paul, MN, announces that they are the first company to begin commercially marketing multi-potent stem cells extracted from cord blood. Their "Multi-Lineage Progenitor Cells™ (MLPCs™)" will be available to researchers and medical companies with an interest in regenerative medicine and drug development. During the past two years, scientists at BioE have successfully differentiated the cloned MLPCs into tissues representative of neural stem cells, nerve cells, liver/pancreas precursors, skeletal muscle, fat cells, bone cells and blood vessels.